Header cover image

U.K. Pharmaceuticals & Biotech Small Cap High Growth Stocks

UPDATED Jul 23, 2022

Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.

12 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
DXRXDiaceuticsUKĀ£0.88-2.8%-19.7%UKĀ£73.8mUKĀ£1.59PE131.6xE34.3%n/a
STXShield TherapeuticsUKĀ£0.065.2%-86.3%UKĀ£13.1mn/aPS8.6xE56.1%n/a
TRXTissue Regenix GroupUKĀ£0.0056.3%-22.9%UKĀ£35.4mn/aPS2.2xE93.4%n/a
CIRCircassia GroupUKĀ£0.34-3.4%14.6%UKĀ£144.7mn/aPE63xE32.6%n/a
DDDD4D pharmaUKĀ£0.170%-80.2%UKĀ£30.0mUKĀ£3.60PS50.3xE28.0%n/a
ARECArecor TherapeuticsUKĀ£3.10-3.1%35.4%UKĀ£86.3mUKĀ£5.28PS74.5xE22.8%n/a
DNLDiurnal GroupUKĀ£0.10-5.7%-83.6%UKĀ£17.4mn/aPS3.3xE58.9%n/a
LLAILungLife AIUKĀ£1.44-0.7%-28.2%UKĀ£36.7mUKĀ£2.89PS225.8xE31.6%n/a
EAHECO Animal Health GroupUKĀ£1.2618.9%-64.0%UKĀ£85.3mUKĀ£2.92PE15.3xE4.6%0.8%
CIZCizzle Biotechnology HoldingsUKĀ£0.0153.6%-73.6%UKĀ£4.0mn/aPB4.3xE41.6%n/a
BVXBiVictriX TherapeuticsUKĀ£0.200%n/aUKĀ£13.6mn/aPB2.1xE35.4%n/a
AVCTAvacta GroupUKĀ£1.09-0.9%-22.1%UKĀ£272.6mUKĀ£1.87PS92.8xE1.9%n/a
Page 1 of 1